Long-Term Safety of Sonidegib in Basal Cell Carcinoma: 30-Month Results from the BOLT Trial. (2018). SKIN The Journal of Cutaneous Medicine, 2(S1), S47. https://doi.org/10.25251/skin.2.supp.47